 Attenuation multisystem organ edema phalloidin antamanide Interleukin potent cytokine diverse effects ability lymphocyte differentiation cells capable tumor therapeutic efficacy limited side effects breakdown microvascular barrier edema Control microvascular barrier part endothelial cell cytoskeletal contractile proteins study cyclopeptides actin filament organization distribution macromolecular flux endothelial cell junction vitro tightness early edema vivo Anesthetized rats periods intravenous saline ml phalloidin micrograms ml micrograms ml min infusion recombinant human saline Six hours start edema group increased wet-to-dry ratios W/D lungs heart kidney bronchoalveolar lavage BAL fluid elevated protein concentration plasma thromboxane levels controls number neutrophils lungs saline controls Phalloidin edema lung reduced BAL protein leak Antamanide treatment effective lung heart edema contrast kidney edema alteration liver W/D Antamanide BAL fluid protein leak